logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Takanori Teshima

hokkaido university
H指数:71
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of lisocabtagene maraleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: 31-month follow-up of the phase 2 TRANSCEND FL study

来那度胺联合利妥昔单抗治疗复发或难治性滤泡性淋巴瘤的疗效与安全性：TRANSCEND FL研究31个月随访结果

International Journal of Clinical Oncology
IF2.8
2026-10-140
OAAI
Shinichi Makita; Hideki Goto; Koji Izutsu; Yuichi Baba; Merav Bar; Maria Strocchia; Prachi Ghodke; Rina Nishii; Takanori Teshima
PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation

PLK1抑制通过激活有丝分裂纺锤体组装检验点增强Brentuximab vedotin对CD30阳性T细胞淋巴瘤的疗效

Leukemia
IF13.4
2026-07-130
PRE
Yuto Mori; Keito Suto; Norio Takei; Keito Yokoyama; Masahiro Chiba; Takashi Ishio; Hideki Goto; Tomoyuki Endo; Hiroo Hasegawa; Michiyuki Maeda; Satoko Otsuguro; Katsumi Maenaka; Takanori Teshima; Yibin Yang; Masao Nakagawa
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemia

使用吉列替尼维持治疗可抑制FLT3突变型复发性/难治性急性髓系白血病移植后复发

Transplantation and Cellular Therapy
IF4.4
2026-04-120
OAAI
Yasuyuki Arai; Marie Ohbiki; Mio Kurata; Shuichi Ota; Masatsugu Tanaka; Kazunori Imada; Takahiro Fukuda; Yuta Katayama; Noriko Doki; Yoshinobu Kanda; Mamiko Sakata-Yanagimoto; Koichi Onodera; Nobuhiro Hiramoto; Noboru Asada; Takashi Ishida; Hiroki Uchida; Satoshi Uno; Takanori Teshima; Akiyoshi Takami; Takaaki Konuma
Subsequent neoplasms after umbilical cord blood transplantation in the Japanese and European populations
Transplantation and Cellular Therapy
IF4.4
2026-01-250
PRE
Junya Kanda; Fernanda Volt; Hanadi Rafii; Hideki Nakasone; Annalisa Ruggeri; Nobuharu Fujii; Chantal Kenzey; Naoyuki Uchida; Régis Peffault De La Tour; Hikaru Kobayashi; Graziana Maria Scigliuolo; Koji Kato; Barbara Cappelli; Fumihiko Ishimaru; Tatsuo Ichinohe; Satoshi Takahashi; Vanderson Rocha; Takanori Teshima; Yoshiko Atsuta; Eliane Gluckman
Safety and efficacy of GVHD prophylaxis with mini-dose methotrexate in umbilical cord blood transplantation – NJHSG-CBT18 observational study –

GVHD预防中使用小剂量甲氨蝶呤在脐带血移植中的安全性与有效性——NJHSG-CBT18观察性研究

Transplantation and Cellular Therapy
IF4.4
2025-11-060
PRE
Souichi Shiratori; Keito Suto; Yuta Hasegawa; Takahide Ara; Toshihiro Matsukawa; Hideki Goto; Masahiro Onozawa; Masao Nakagawa; Kaoru Kahata; Daisuke Hidaka; Reiki Ogasawara; Kohei Okada; Junichi Sugita; Yasutaka Kakinoki; Shuichi Ota; Daigo Hashimoto; Takanori Teshima
A characteristic gene expression profile regulated by ACIN1::NUTM1 fusion in a newly identified infant leukaemic cell line and an ACIN1::NUTM1-inducible model

由ACIN1::NUTM1融合调控的特征性基因表达谱：在一个新鉴定的婴儿白血病细胞系及ACIN1::NUTM1可诱导模型中

British Journal of Haematology
IF3.8
2025-08-290
OAAI
Minori Tamai; Chiaki Komatsu; Keiko Kagami; Shin Kasai; Atsushi Watanabe; Koshi Akahane; Kumiko Goi; Chihiro Tomoyasu; Toshihiko Imamura; Satoshi Oguri; Sumio Iwasaki; Takanori Teshima; Yasushi Yatabe; Takeshi Inukai
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases

雷德西韦抗性突变在患有各种免疫抑制疾病的COVID-19患者中的表征

Antiviral Research
IF4
2025-08-280
PREAI
Takaya Ichikawa; Tomokazu Tamura; Naganori Nao; Hikoyu Suzuki; Shuhei Maruyama; Daiki Wada; Shuhei Tsujino; Noriyoshi Yoshinaga; Kohsuke Asagoe; Mutsumi Takahata; Takashi Ishio; Makoto Ibata; Tanino Yoko; Yasutaka Kakinoki; Kazuhiro Okubo; Rigel Suzuki; Saori Suzuki; Yasushi Nakamori; Takanori Teshima; Takasuke Fukuhara
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net

与第一周期阿扎胞苷-维奈克拉组合中14天、21天或标准28天维奈克拉治疗相比，在未经治疗的急性髓系白血病中具有可比的结果：来自北海道白血病网的现实世界经验

Blood Cancer Journal
IF11.6
2025-07-030
OAAI
Minoru Kanaya; Masahiro Onozawa; Toshihiro Matsukawa; Naoki Miyashita; Fumiaki Fujii; Shota Yoshida; Jun Nagai; Masayuki Aiba; Daisuke Hidaka; Junichi Hashiguchi; Hajime Senjo; Tetsuyuki Igarashi; Masahiro Chiba; Satoshi Yamamoto; Taku Shimizu; Takashi Ishio; Shota Yokoyama; Ko Ebata; Satoshi Iyama; Tatsuo Oyake; Takeshi Kondo; Takanori Teshima
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

急性GVHD第28天治疗反应标准的修订：JSTCT与MAGIC的合作研究

Blood Advances
IF7.1
2025-07-030
OAAI
Yu Akahoshi; Yoshihiro Inamoto; Nikolaos Spyrou; Hideki Nakasone; Marcio A. Diniz; Noboru Asada; Francis Ayuk; Hannah K. Choe; Noriko Doki; Tetsuya Eto; Aaron M. Etra; Elizabeth O. Hexner; Nobuhiro Hiramoto; William J. Hogan; Ernst Holler; Keisuke Kataoka; Toshiro Kawakita; Masatsugu Tanaka; Takashi Tanaka; Naoyuki Uchida; Ingrid Vasova; Satoshi Yoshihara; Fumihiko Ishimaru; Takahiro Fukuda; Yi-Bin Chen; Junya Kanda; Ryotaro Nakamura; Yoshiko Atsuta; James L. M. Ferrara; Yoshinobu Kanda; John E. Levine; Takanori Teshima
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma

TP53和CDKN2A的异常改变定义了结节性T滤泡辅助细胞淋巴瘤患者中一个预后不良的亚群。

LEUKEMIA
IF13.4
2025-05-020
PRE
Ito, Yuta; Shimono, Joji; Kawamoto, Keisuke; Hatanaka, Kanako C.; Kogure, Yasunori; Tabata, Mariko; Saito, Yuki; Mizuno, Kota; Horie, Sara; Mizukami, Yosuke; Koya, Junji; Murakami, Koichi; Teshima, Takanori; Hatanaka, Yutaka; Chiba, Kenichi; Okada, Ai; Shiraishi, Yuichi; Miyoshi, Hiroaki; Matsuno, Yoshihiro; Ohshima, Koichi; Kataoka, Keisuke; Nakagawa, Masao
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma

单次注射pegfilgrastim对多发性骨髓瘤或恶性淋巴瘤患者外周血干细胞采集的影响

SCIENTIFIC REPORTS
IF3.9
2025-04-250
OA
Goto, Hideki; Sawa, Masashi; Fujiwara, Shin-ichiro; Ri, Masaki; Ishida, Tadao; Takeuchi, Masahiro; Ishitsuka, Kenji; Toyosaki, Masako; Sunami, Kazutaka; Tsukada, Junichi; Sonoki, Takashi; Shimogomi, Aiko; Ichihashi, Yuki; Ouchi, Yoshiumi; Miyamoto, Toshihiro; Hino, Masayuki; Maeda, Yoshinobu; Teshima, Takanori
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies
TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2024-12-013
PRE
Kongtim, Piyanuch; Vittayawacharin, Pongthep; Zou, Jun; Srour, Samer; Shaffer, Brian; Shapiro, Roman M.; Varma, Ankur; Mcguirk, Joseph; Dholaria, Bhagirathbhai R.; Mccurdy, Shannon R.; Dezern, Amy E.; Bejanyan, Nelli; Bashey, Asad; Furst, Sabine; Castagna, Luca; Mariotti, Jacopo; Ruggeri, Annalisa; Bailen, Rebeca; Teshima, Takanori; Xiao-Jun, Huang; Bonfim, Carmen; Aung, Fleur; Cao, Kai; Carpenter, Paul A.; Hamadani, Mehdi; Askar, Medhat; Fernandez-Vina, Marcelo; Girnita, Alin; Ciurea, Stefan O.

研究方向

暂未获取到该数据
D
Daigo Hashimoto
H 指数:41论文数:236被引数:1.4万
M
Masahiro Onozawa
H 指数:31论文数:246被引数:3,634
J
Junichi Sugita
H 指数:30论文数:209被引数:3,799
T
Takeshi Kondo
H 指数:36论文数:295被引数:5,956
H
Hideki Goto
H 指数:21论文数:242被引数:1,518
S
Souichi Shiratori
H 指数:21论文数:144被引数:1,593
H
Hajime Senjo
H 指数:12论文数:55被引数:681
J
James L.M. Ferrara
H 指数:91论文数:450被引数:2.9万
S
Shuichi Ota
H 指数:31论文数:367被引数:3,617
M
Masao Nakagawa
H 指数:50论文数:829被引数:1.0万